CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion

Jerry F Tien1, Alborz Mazloomian2,3, S-W Grace Cheng1

  • 1Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada.

Nucleic Acids Research
|March 24, 2017
PubMed

Insights

Cyclin-dependent kinase 12 (CDK12) primarily regulates alternative last exon splicing, impacting DNA repair and cell invasion in breast cancer. CDK12 amplification correlates with increased tumor cell migration and invasiveness, suggesting a role in cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Genomics
  • Transcriptional Regulation

Background:

  • Cyclin-dependent kinase 12 (CDK12) is a regulatory kinase involved in transcription elongation.
  • Recurrent CDK12 mutations are found in breast and ovarian cancers, potentially disrupting DNA repair.
  • CDK12 is often co-amplified with the HER2 oncogene in breast cancers, but its precise functions remain unclear.

Purpose of the Study:

  • To investigate the mechanisms of CDK12 function in cancer.
  • To determine the role of CDK12 in breast cancer pathogenesis.
  • To analyze the impact of CDK12 amplification on mRNA splicing and tumor cell behavior.

Main Methods:

  • Global mRNA transcript analysis in normal and breast cancer cell lines.
  • Comparison of cell lines with and without CDK12 amplification.
  • Assessment of alternative last exon (ALE) splicing patterns.
  • Correlation analysis between CDK12 levels, DNAJB6 isoforms, and cell migration/invasion.

Main Results:

  • CDK12 primarily regulates gene- and cell type-specific alternative last exon (ALE) splicing.
  • CDK12 modulates ALE splicing of ATM and a DNAJB6 isoform in breast cancer cells.
  • CDK12 levels directly correlate with DNAJB6 isoform levels, cell migration, and invasiveness.

Conclusions:

  • CDK12's primary role is regulating specific ALE splicing events.
  • CDK12 amplification in breast cancer can contribute to pathogenesis by influencing DNA repair and cell invasion.
  • Targeting CDK12 may offer therapeutic strategies for breast cancer.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K